Sepsis is a major global healthcare problem that affects over 18 million individuals per year, every single year, corresponding to 1,400 deaths per day. In Europe and the US alone, there are an estimated 135,000 and 215,000 causalities and €7.6 and €17.4 billion related treating costs, respectively.
Using experimental models of sepsis in mice the research team led by Miguel Soares at the Instituto Gulbenkian de Ciência in Portugal discovered an unsuspected mechanism that is protective against sepsis. This study that provides new avenues for therapeutic approaches against sepsis appears in the June 15 issue of the prestigious scientific journal Cell*.
Despite being more common than heart attack and more lethal than cancer, the large majority people do not really know what sepsis is. Briefly, it consists of an uncontrolled body’s response to an infection that is spreading towards different parts of the body, also know as a systemic infection. The immune system of the infected individual does try to kill the microbes responsible for the infection, and in many cases manages to do so, but in the process causes profound alterations in the normal functioning of vital organs, such as, the brain, heart, liver, kidney or lungs. In more severe cases blood pressure also drops and those organs ultimately stop functioning properly and as a result the patient dies.
It is well know that sepsis patients vary in their response to infection and disease severity, depending on the type of infection as well as on their genetic characteristics, coexisting illnesses and age. A long lasting unsolved mystery relates to why despite an effective control of the infectious microorganisms by the use antibiotics, some patients succumb while others recover from the infection. Over the past five years the research team led by Miguel Soares has put forward the concept that those individuals that do not succumb to sepsis develop a protective response that maintains the function of vital organs, conferring disease tolerance to the infection. Using experimental models of sepsis in mice they now discovered a mechanism that is vital to confer disease tolerance to sepsis.
“We knew that a key element to promote disease tolerance to infection is how the levels of iron are controlled in different tissues while other colleagues had shown that the pathogenesis of sepsis is associated with deregulation of glucose (sugar) metabolism. What we found is that these two phenomena are intimately linked in that controlling iron metabolism is required to sustain the production of glucose in the liver so that glucose can be used as a vital source of energy by other organs”, says Miguel Soares.
Sebastian Weis a Medical Doctor doing is post-doctoral training with Miguel Soares induced sepsis in laboratory mice and compared how disease progresses in mice that express or not ferritin, a protein that controls iron in the liver. He found that ferritin is absolutely required for the liver to produce glucose after an infection and hence to protect mice from succumbing to sepsis.
“Typically in mice, after infection, there is an increase of blood glucose levels followed by a quick drop, which can become lethal. In humans with infectious disease this also occurs in a subset of patients and is know to lead to higher death rates. Our results showed that ferritin controls glucose production in the liver so that blood glucose levels are maintained within a range that allows survival. Without ferritin, the glucose levels continued to drop and mice eventually die from sepsis”, explains Sebastian Weis, co-first author of the manuscript and currently a researcher and clinician at the Jena University Hospital, Germany, where part of the experiments were conducted.”
Another key piece of this puzzle was provided by Ana Rita Carlos, a PhD working as a post-doctoral fellow with Miguel Soares. She found that the reason why ferritin is required for the liver to produce glucose relies on a molecular mechanism that controls the expression of one of the key genes involved in this process, known as glucose 6 phosphatase. When ferritin is absent, iron deregulates the expression of Glucose 6 phosphatase and the liver loses its capacity to secrete glucose. When this occurs, glucose cannot be delivered and used by other vital organs as a source of energy. This is required to maintain the function of those organs in response to infection and as such to prevent the development of lethal forms of sepsis. This protective mechanism does no influence the microorganisms that are the underlying cause of the disease and as such is said to confer disease tolerance to sepsis.
“It is very interesting that while essential to support many vital cellular functions iron must be tightly controlled in the liver so that it cannot interfere with the production of glucose. The molecular mechanism via which this occurs relies on the expression of ferritin, a protein complex that binds iron and devoid iron from interfering with glucose production” explains Ana Rita Carlos, also a co-first author of the manuscript.
“This is a great example on how basic research conducted in a multidisciplinary environment such as the one provided by the Instituto Gulbenkian de Ciência, without an immediate commercial interest, can have a global impact on the treatment of a major disease that affects over 18 million individuals per year worldwide. Our mission is to make discoveries so that these can be eventually translated into treatments of major diseases”. says Miguel Soares.
Learn more: A Rusty and Sweet Side of Sepsis
The Latest on: Sepsis
- Sepsis detector among innovations to be ‘spread across NHS’ on November 20, 2017 at 6:52 am
Ten months until I qualify. The time has not flown - it has used a very high speed internet connection to instantly bring me face to face with my career, leaving me clutching tightly to my three striped epaulettes. I met a nurse at the Nursing Times Awards ... […]
- The £40 smart plaster that spots sepsis SIX hours early: Gadget to be fast-tracked into hospitals after trials show it could boost survival rates on November 19, 2017 at 5:01 pm
A smart plaster that detects the early signs of sepsis is to be fast-tracked into NHS hospitals. Trials of the Respira Sense device show it can identify a deteriorating patient an average of six hours earlier than current methods, significantly boosting ... […]
- Pharmacist, 27, nearly died from sepsis caused by rare complication of miscarriage – just days after she found out she was expecting on November 18, 2017 at 1:27 pm
A PHARMACIST almost died after contracting deadly sepsis when she suffered a miscarriage. Rachel Pilgrim found out she was pregnant just five days before she miscarried and started to experience flu-like symptoms. The 27-year-old, from Bath, developed a ... […]
- Teenage MMA fighter faces surgery to save leg after being hit by meningitis and 'flesh eating' sepsis on November 17, 2017 at 6:41 pm
A teenage martial arts fighter who contracted meningitis and then 'flesh eating' sepsis faces life-changing surgery to save her right leg. Surgeons plan to remove muscles from Amy Burton's back and implant them into her leg, which has turned black and ... […]
- Sepsis Diagnostics Market Global Industry Analysis and Opportunity Assessment, Forecast to 2022 on November 16, 2017 at 7:22 am
Market Research Future Published Analysis report on “Sepsis Diagnostics Market Research Report- Global Forecast to 2022” – Market Analysis, Stake, Progress, Trends, Scope and Forecast to 2022. Pune, India -- (SBWIRE) -- 11/16/2017 -- Sepsis ... […]
- Sepsis Diagnostics Market Value Predicted to Reach USD 564.1 million by 2021 on November 15, 2017 at 4:15 am
Browse Details of Global Sepsis Diagnostics Market Research Report @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/ Sepsis can be defined as the body’s reaction to the fungal, bacterial, viral, or parasitic infection ... […]
- Sepsis Diagnostics Market Estimated to Grow at 8.8% CAGR during 2016 to 2021 on November 14, 2017 at 10:58 pm
The Global Sepsis Diagnostics Market was worth USD 370 million in 2016 and estimated to be growing at a CAGR of 8.8%, to reach USD 564.1 million by 2021. The increasing prevalence of the disease and its fatal effects has stimulated its growth. Browse ... […]
- Research team led by UCR scientist finds potential treatment for sepsis on November 13, 2017 at 1:52 pm
A research team led by a biomedical scientist at UC Riverside has discovered that the human protein resistin could be used to treat sepsis, the body’s extreme and uncontrolled immune response to an infection. Without timely treatment, sepsis can rapidly ... […]
- Breakthrough in battle against sepsis on November 13, 2017 at 7:00 am
Australian researchers have discovered a molecule that could be used to treat sepsis, potentially saving millions of lives each year. Sepsis occurs when the body's immune response to an infection starts to damage its own tissues and organs. It causes ... […]
- Researchers Identify Hormone for Treating Sepsis on November 13, 2017 at 12:00 am
Photo shows Meera Nair (left) and Jessica Jang in the Nair laboratory at the UCR School of Medicine.Photo credit: Ross French, UC Riverside. RIVERSIDE, Calif. – A research team led by a biomedical scientist at the University of California, Riverside has ... […]
via Google News and Bing News